Josias Fantato De Pontes
Director of Finance/CFO at SIGILON THERAPEUTICS, INC.
Net worth: - $ as of 2023-07-30
Profile
Josias Fantato De Pontes is currently the Treasurer, Chief Financial & Accounting Officer at Sigilon Therapeutics, Inc. He previously worked as the Senior Director-Accounting Reporting at Catalent JNP, Inc. from 2016 to 2018, the Senior Director-Rare Diseases Finance at Genzyme Corp.
from 2011 to 2015, and the Senior Director-Financial Planning & Analysis at Zafgen, Inc. from 2017 to 2019.
Mr. De Pontes holds an MBA from The Ohio University and an undergraduate degree from Fundação Escola de Comércio Álvares Penteado.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-10 | 0 ( -.--% ) | - $ | 2023-07-30 |
Josias Fantato De Pontes active positions
| Companies | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Director of Finance/CFO | 2022-02-17 |
Former positions of Josias Fantato De Pontes
| Companies | Position | End |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | 2019-08-30 |
| JUNIPER PHARMACEUTICALS INC | Corporate Officer/Principal | 2017-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Comptroller/Controller/Auditor | 2007-04-30 |
Training of Josias Fantato De Pontes
| The Ohio University | Masters Business Admin |
| Fundação Escola de Comércio Álvares Penteado | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Josias Fantato De Pontes
